AKT1 and cancer: Aberrant activation of EGFR stimulates several intracellular signaling pathways—Phosphoinositide 3-kinase (PI3K)/AKT, RAS/RAF/MEK/ERK, Src/signal transducer and activator of transcription (STAT)—Which in turn cause augmented cell proliferation and other oncogenic characteristics in cancers [6].